P

Promentis Pharmaceuticals, Inc.

4 employees

Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Medical
Pharmaceutical

Date founded

2007

Funding rounds raised

Total raised

$26M

from 12 investors over 12 rounds

P

Promentis Pharmaceuticals, Inc. raised $26M on March 30, 2017

Investors: Golden Triangle Angelnet, Aisling Capital, F-Prime Capital Partners, OrbiMed Advisors and Black Pearl Capital

P

Promentis Pharmaceuticals, Inc. raised $8.7M on October 10, 2016

Investors: Golden Angels Investors and F-Prime Capital Partners

P

Promentis Pharmaceuticals, Inc. raised $2.9M on January 17, 2014

Investors: Golden Angels Investors

P

Promentis Pharmaceuticals, Inc. raised $750K on April 1, 2013

Investors: Golden Angels Investors

P

Promentis Pharmaceuticals, Inc. raised $1.8M on September 25, 2012

Investors: National Institutes of Health

P

Promentis Pharmaceuticals, Inc. raised $1.9M on February 25, 2010

Investors: Golden Angels Investors

P

Promentis Pharmaceuticals, Inc. raised $1.7M on August 31, 2009

Investors: Golden Angels Investors

FAQ